<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p56" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_56{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_56{left:341px;bottom:30px;}
#t3_56{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_56{left:377px;bottom:30px;}
#t5_56{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_56{left:540px;bottom:30px;}
#t7_56{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_56{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_56{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_56{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_56{left:285px;bottom:827px;letter-spacing:-0.24px;}
#tc_56{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_56{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_56{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_56{left:1098px;bottom:28px;letter-spacing:0.32px;}
#tg_56{left:36px;bottom:215px;}
#th_56{left:46px;bottom:209px;letter-spacing:0.13px;}
#ti_56{left:247px;bottom:209px;}
#tj_56{left:36px;bottom:200px;}
#tk_56{left:47px;bottom:192px;letter-spacing:0.13px;}
#tl_56{left:262px;bottom:192px;}
#tm_56{left:36px;bottom:183px;}
#tn_56{left:43px;bottom:176px;letter-spacing:0.13px;word-spacing:-0.06px;}
#to_56{left:337px;bottom:176px;}
#tp_56{left:36px;bottom:166px;}
#tq_56{left:42px;bottom:159px;letter-spacing:0.12px;word-spacing:0.01px;}
#tr_56{left:45px;bottom:142px;letter-spacing:0.12px;}
#ts_56{left:268px;bottom:142px;letter-spacing:0.13px;}
#tt_56{left:352px;bottom:142px;}
#tu_56{left:36px;bottom:133px;}
#tv_56{left:46px;bottom:125px;letter-spacing:0.12px;word-spacing:-0.03px;}
#tw_56{left:556px;bottom:125px;}
#tx_56{left:36px;bottom:116px;}
#ty_56{left:50px;bottom:108px;letter-spacing:0.12px;}
#tz_56{left:82px;bottom:108px;letter-spacing:0.12px;}
#t10_56{left:160px;bottom:108px;letter-spacing:0.08px;word-spacing:0.05px;}
#t11_56{left:36px;bottom:778px;letter-spacing:0.48px;}
#t12_56{left:36px;bottom:760px;letter-spacing:0.25px;}
#t13_56{left:194px;bottom:778px;letter-spacing:0.32px;word-spacing:-0.31px;}
#t14_56{left:665px;bottom:778px;letter-spacing:0.29px;}
#t15_56{left:665px;bottom:760px;letter-spacing:0.3px;}
#t16_56{left:36px;bottom:641px;letter-spacing:-0.11px;}
#t17_56{left:36px;bottom:400px;letter-spacing:-0.1px;}
#t18_56{left:36px;bottom:382px;letter-spacing:-0.09px;}
#t19_56{left:36px;bottom:363px;letter-spacing:-0.1px;}
#t1a_56{left:194px;bottom:661px;letter-spacing:-0.15px;word-spacing:0.05px;}
#t1b_56{left:194px;bottom:643px;letter-spacing:-0.08px;}
#t1c_56{left:194px;bottom:625px;letter-spacing:-0.09px;}
#t1d_56{left:389px;bottom:632px;}
#t1e_56{left:194px;bottom:471px;letter-spacing:-0.1px;}
#t1f_56{left:194px;bottom:452px;letter-spacing:-0.1px;}
#t1g_56{left:360px;bottom:460px;letter-spacing:-0.09px;}
#t1h_56{left:194px;bottom:416px;letter-spacing:-0.1px;}
#t1i_56{left:194px;bottom:379px;letter-spacing:-0.08px;}
#t1j_56{left:194px;bottom:342px;letter-spacing:-0.1px;}
#t1k_56{left:194px;bottom:306px;letter-spacing:-0.1px;}
#t1l_56{left:389px;bottom:313px;letter-spacing:-0.11px;}
#t1m_56{left:554px;bottom:708px;letter-spacing:-0.09px;}
#t1n_56{left:554px;bottom:690px;letter-spacing:-0.09px;}
#t1o_56{left:554px;bottom:672px;letter-spacing:-0.1px;}
#t1p_56{left:678px;bottom:679px;}
#t1q_56{left:554px;bottom:620px;letter-spacing:-0.08px;}
#t1r_56{left:554px;bottom:602px;letter-spacing:-0.09px;}
#t1s_56{left:619px;bottom:609px;}
#t1t_56{left:815px;bottom:699px;letter-spacing:-0.1px;}
#t1u_56{left:982px;bottom:707px;letter-spacing:-0.07px;}
#t1v_56{left:815px;bottom:681px;letter-spacing:-0.09px;}
#t1w_56{left:815px;bottom:640px;letter-spacing:-0.13px;}
#t1x_56{left:839px;bottom:648px;}
#t1y_56{left:815px;bottom:622px;letter-spacing:-0.06px;}
#t1z_56{left:815px;bottom:604px;letter-spacing:-0.26px;word-spacing:-0.74px;}
#t20_56{left:815px;bottom:585px;letter-spacing:-0.1px;}
#t21_56{left:904px;bottom:593px;letter-spacing:-0.07px;}
#t22_56{left:1066px;bottom:711px;letter-spacing:-0.1px;}
#t23_56{left:1066px;bottom:692px;letter-spacing:-0.09px;}
#t24_56{left:1066px;bottom:674px;letter-spacing:-0.08px;}
#t25_56{left:1068px;bottom:626px;letter-spacing:-0.09px;}
#t26_56{left:1068px;bottom:608px;letter-spacing:-0.06px;}
#t27_56{left:1068px;bottom:590px;letter-spacing:-0.08px;}
#t28_56{left:1068px;bottom:571px;letter-spacing:-0.09px;}
#t29_56{left:1068px;bottom:553px;letter-spacing:-0.25px;}
#t2a_56{left:799px;bottom:306px;letter-spacing:-0.11px;word-spacing:-0.62px;}
#t2b_56{left:987px;bottom:306px;letter-spacing:-0.11px;}
#t2c_56{left:554px;bottom:324px;letter-spacing:-0.09px;}
#t2d_56{left:554px;bottom:305px;letter-spacing:-0.09px;}
#t2e_56{left:554px;bottom:287px;letter-spacing:-0.09px;}
#t2f_56{left:554px;bottom:269px;letter-spacing:-0.11px;}
#t2g_56{left:592px;bottom:276px;}
#t2h_56{left:937px;bottom:470px;letter-spacing:-0.09px;}
#t2i_56{left:937px;bottom:451px;letter-spacing:-0.09px;}
#t2j_56{left:1003px;bottom:451px;letter-spacing:-0.25px;}
#t2k_56{left:550px;bottom:472px;letter-spacing:-0.1px;}
#t2l_56{left:550px;bottom:452px;letter-spacing:-0.09px;}
#t2m_56{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_56{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_56{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_56{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_56{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_56{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_56{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_56{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s7_56{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.s8_56{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.s9_56{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.sa_56{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.sb_56{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts56" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg56Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg56" style="-webkit-user-select: none;"><object width="1210" height="935" data="56/56.svg" type="image/svg+xml" id="pdf56" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_56" class="t s0_56">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_56" class="t s1_56">® </span>
<span id="t3_56" class="t s0_56">(NCCN </span>
<span id="t4_56" class="t s1_56">® </span>
<span id="t5_56" class="t s0_56">), All rights reserved. NCCN Guidelines </span>
<span id="t6_56" class="t s1_56">® </span>
<span id="t7_56" class="t s0_56">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_56" class="t s2_56">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_56" class="t s2_56">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_56" class="t s3_56">NCCN Guidelines Version 4.2024 </span>
<span id="tb_56" class="t s3_56">Cancer of the Supraglottic Larynx </span>
<span id="tc_56" class="t s4_56">NCCN Guidelines Index </span>
<span id="td_56" class="t s4_56">Table of Contents </span>
<span id="te_56" class="t s4_56">Discussion </span>
<span id="tf_56" class="t s5_56">SUPRA-8 </span>
<span id="tg_56" class="t s6_56">d </span>
<span id="th_56" class="t s7_56">Principles of Imaging (IMG-A)</span><span id="ti_56" class="t s8_56">. </span>
<span id="tj_56" class="t s6_56">h </span>
<span id="tk_56" class="t s7_56">Principles of Surgery (SURG-A)</span><span id="tl_56" class="t s8_56">. </span>
<span id="tm_56" class="t s6_56">i </span>
<span id="tn_56" class="t s7_56">Principles of Radiation Therapy (SUPRA-A)</span><span id="to_56" class="t s8_56">. </span>
<span id="tp_56" class="t s6_56">j </span>
<span id="tq_56" class="t s8_56">Adverse pathologic features: extranodal extension, positive margins, close margins, pT3 or pT4 primary, pN2 or pN3 nodal disease, perineural invasion, vascular </span>
<span id="tr_56" class="t s8_56">invasion, and lymphatic invasion </span><span id="ts_56" class="t s7_56">(Discussion)</span><span id="tt_56" class="t s8_56">. </span>
<span id="tu_56" class="t s6_56">k </span>
<span id="tv_56" class="t s7_56">Principles of Systemic Therapy for Non-Nasopharyngeal Cancers (SYST-A)</span><span id="tw_56" class="t s8_56">. </span>
<span id="tx_56" class="t s6_56">m </span>
<span id="ty_56" class="t s8_56">See </span><span id="tz_56" class="t s7_56">Discussion </span><span id="t10_56" class="t s8_56">on induction chemotherapy. </span>
<span id="t11_56" class="t s5_56">CLINICAL </span>
<span id="t12_56" class="t s5_56">STAGING </span>
<span id="t13_56" class="t s5_56">TREATMENT OF PRIMARY AND NECK </span><span id="t14_56" class="t s5_56">ADJUVANT </span>
<span id="t15_56" class="t s5_56">TREATMENT </span>
<span id="t16_56" class="t s5_56">T4a,N0–N3 </span>
<span id="t17_56" class="t s5_56">T4a,N0–N3 </span>
<span id="t18_56" class="t s5_56">patients who </span>
<span id="t19_56" class="t s5_56">decline surgery </span>
<span id="t1a_56" class="t s5_56">Laryngectomy, thyroidectomy </span>
<span id="t1b_56" class="t s5_56">as indicated with ipsilateral or </span>
<span id="t1c_56" class="t s5_56">bilateral neck dissection </span>
<span id="t1d_56" class="t s9_56">h </span>
<span id="t1e_56" class="t s5_56">Consider concurrent </span>
<span id="t1f_56" class="t s5_56">systemic therapy/RT </span>
<span id="t1g_56" class="t s9_56">i,k </span>
<span id="t1h_56" class="t s5_56">or </span>
<span id="t1i_56" class="t s5_56">Clinical trial </span>
<span id="t1j_56" class="t s5_56">or </span>
<span id="t1k_56" class="t s5_56">Induction chemotherapy </span>
<span id="t1l_56" class="t s9_56">k,m </span>
<span id="t1m_56" class="t s5_56">Extranodal </span>
<span id="t1n_56" class="t s5_56">extension and/or </span>
<span id="t1o_56" class="t s5_56">positive margin </span>
<span id="t1p_56" class="t s9_56">j </span>
<span id="t1q_56" class="t s5_56">Other risk </span>
<span id="t1r_56" class="t s5_56">features </span>
<span id="t1s_56" class="t s9_56">j </span>
<span id="t1t_56" class="t s5_56">Systemic therapy/RT </span>
<span id="t1u_56" class="t s9_56">i,k </span>
<span id="t1v_56" class="t s5_56">(category 1) </span>
<span id="t1w_56" class="t s5_56">RT </span>
<span id="t1x_56" class="t s9_56">i </span>
<span id="t1y_56" class="t s5_56">or </span>
<span id="t1z_56" class="t s5_56">Consider systemic </span>
<span id="t20_56" class="t s5_56">therapy/RT </span>
<span id="t21_56" class="t s9_56">i,k </span>
<span id="t22_56" class="t s5_56">Follow-up </span>
<span id="t23_56" class="t sa_56">(FOLL-A, 1 </span>
<span id="t24_56" class="t sa_56">of 2) </span>
<span id="t25_56" class="t s5_56">Recurrent </span>
<span id="t26_56" class="t s5_56">or </span>
<span id="t27_56" class="t s5_56">persistent </span>
<span id="t28_56" class="t s5_56">disease </span>
<span id="t29_56" class="t sa_56">(ADV-3) </span>
<span id="t2a_56" class="t s5_56">Response Assessment </span><span id="t2b_56" class="t sa_56">(SUPRA-7) </span>
<span id="t2c_56" class="t s5_56">CT (with contrast) or </span>
<span id="t2d_56" class="t s5_56">MRI (with and without </span>
<span id="t2e_56" class="t s5_56">contrast) of primary and </span>
<span id="t2f_56" class="t s5_56">neck </span>
<span id="t2g_56" class="t s9_56">d </span>
<span id="t2h_56" class="t s5_56">Recurrent or persistent </span>
<span id="t2i_56" class="t s5_56">disease </span><span id="t2j_56" class="t sa_56">(ADV-3) </span>
<span id="t2k_56" class="t sa_56">Post Systemic Therapy/RT or RT </span>
<span id="t2l_56" class="t sa_56">Neck Evaluation (FOLL-A, 2 of 2) </span>
<span id="t2m_56" class="t sb_56">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
